OpenAI introduces new technology that can supposedly “think”
Good morning, Quartz readers! WHAT YOU NEED TO KNOW OpenAI says its products will soon start thinking. The company’s latest models will pause for a while to spit out answers to increasingly complex queries. Trump Media shares on a losing…
Amazon, Apple, Anglo American and Novo Nordisk
Amazon is expected to report earnings of 83 cents per share on revenue of $142.495 billion. (Reuters) Earnings season is in full swing and investors have high expectations for the mega-caps reporting results next week, such as Amazon and Apple….
This weight loss stock is up 74% so far this year and is about to crash
Weight loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are conquering the pharmaceutical industry. While Eli Lilly And Novo Nordisk are major players in diabetes and obesity treatment thanks to their glucagon-like peptide-1 (GLP-1) agonists, but many companies are…
What Eli Lilly and Novo Nordisk’s earnings reveal about the future of GLP-1 sales
It was an exciting, if sometimes uncertain, year for the GLP-1 business. Just take a look at the past week. On Wednesday, Novo Nordisk (NVO) missed Wall Street estimates for second-quarter GLP-1 sales, citing ongoing supply shortages of weight-loss drug…
